| Recent BMA Stock Price | BMA Stock Predictions | |
| $70.80 | ![]() +58.43% |
$112.17 |
| Recent BMA Analyst Ratings Breakdown, Making BMA Stock Predictions | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 6 | 6 | 6 | 6 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 2 | 1 | 1 | 1 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 1 | 1 | 1 |
| Average rating: | 1.44 | 1.69 | 1.69 | 1.69 |
For the BMA stock predictions from the analysts covering Banco Macro SA, we have collected all of the individual BMA stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 6 different analysts covering BMA (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since BMA stock predictions may vary widely, another useful metric to consider is the median BMA stock prediction, which represents the price at which half of the analysts
made BMA stock predictions that were higher and half made BMA stock predictions that were lower. This makes for a different take on the BMA stock predictions out there, as compared to average or mean.
And that median across all the individual BMA stock predictions was: $119.0 as of 2026-05-18.
The very highest of the BMA stock predictions for one year price target was $130.0, while the very lowest of the BMA stock predictions in the analyst group was
$85.0 (with a standard deviation of $18.291). Get the latest Zacks research report on BMA — FREE
Awesome: BMA is a monthly dividend paying stock »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
• FFG Stock Predictions
• BOMN Stock Predictions
• UNTY Stock Predictions
• EEX Stock Predictions
• NBR Stock Predictions
• QUMU Stock Predictions
• ESI Stock Predictions
• CVA Stock Predictions
• PCAR Stock Predictions
|
||||||||||||
|
Quotes delayed 20 minutes
|
Strong Buy (3.56 out of 4) 89th percentile
(ranked higher than approx. 89% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |